Cargando…
Fe(III)-Shikonin supramolecular nanomedicines as immunogenic cell death stimulants and multifunctional immunoadjuvants for tumor vaccination
Immunoadjuvants, as an indispensable component of tumor vaccines, can observably enhance the magnitude, breadth, and durability of antitumor immunity. However, current immunoadjuvants suffer from different issues such as weak immunogenicity, inadequate cellular internalization, poor circulation time...
Autores principales: | Feng, Wenjie, Shi, Wanrui, Cui, Yanqi, Xu, Jiajun, Liu, Shuwei, Gao, Hang, Zhu, Shoujun, Liu, Yi, Zhang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614674/ https://www.ncbi.nlm.nih.gov/pubmed/37908730 http://dx.doi.org/10.7150/thno.81650 |
Ejemplares similares
-
Promising Nanomedicines of Shikonin for Cancer Therapy
por: Yan, Chunmei, et al.
Publicado: (2023) -
Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines
por: Abbasi, Saed, et al.
Publicado: (2021) -
Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants
por: Moreau, Michele, et al.
Publicado: (2018) -
Silica-based cationic bilayers as immunoadjuvants
por: Lincopan, Nilton, et al.
Publicado: (2009) -
Combination of an autophagy inhibitor with immunoadjuvants and an anti-PD-L1 antibody in multifunctional nanoparticles for enhanced breast cancer immunotherapy
por: Cheng, Yibin, et al.
Publicado: (2022)